Targeted regulation of cytokines expression with a portable smart light-controllable device for tumor immunotherapy
Ontology highlight
ABSTRACT: As the first type of tumor immunotherapy drugs, cytokines have attracted sustained attention due to their multi-functional cellular response in immunotherapy. However, the application of cytokines for tumor immunotherapy was still limited to their short half-time, narrow therapeutic window, and undesired side effects. Here, we constructed a portable smart light-controllable (PSLC) device to address this issue. By combining the PSLC device and light-switchable gene modules, it is theoretically possible to regulate the cytokines expressed within target tumors by optical remote control. Then, cytokine interferon-γ (IFN-γ) and chemokine CXCL10, two essential immune regulatory molecules that play crucial roles in immunotherapy, are selected to test this system.
ORGANISM(S): Mus musculus
PROVIDER: GSE214760 | GEO | 2022/10/07
REPOSITORIES: GEO
ACCESS DATA